Upgrade to SI Premium - Free Trial

Zimmer Biomet (ZBH) PT Lowered to $175 at Truist Securities

November 4, 2021 6:09 PM
Truist Securities analyst Kaila Krum lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $188.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles